Evidence map›Paper›PMID 23186530›Full record

ArticleNano letters2013

Nanostructure-mediated transport of biologics across epithelial tissue: enhancing permeability via nanotopography.

Kimberly R Kam, Laura A Walsh, Suzanne M Bock, Michael Koval, Kathleen E Fischer, Russell F Ross, Tejal A Desai

Registry-linked trialAbstract read
In one paragraph

Article in Nano letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03229798 (An Open-Label Phase 1 Study to Establish the Pharmacokinetics and Safety of Sumatriptan Succinate Administered Via the Sofusa™ DoseConnect™ System at Escalating Doses Compared to Oral Imitrex® Single 100 mg Dose in Healthy Subjects), which is not on this map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03229798 phase1completednot on this mapstarted 2018, after this paper: background citation

An Open-Label Phase 1 Study to Establish the Pharmacokinetics and Safety of Sumatriptan Succinate Administered Via the Sofusa™ DoseConnect™ System at Escalating Doses Compared to Oral Imitrex® Single 100 mg Dose in Healthy Subjects

TypeinterventionalSponsorSorrento Therapeutics, Inc.Ran2018 to 2018Enrolled19ConditionsMigraine DisordersArmsSumatriptan Succinate Oral Tablet, Transdermal delivery of sumatriptan succinate
3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Above the Matrix: Functional Roles for Apically Localized Integrins.Frontiers in cell and developmental biology · 2021
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Micro and nanoscale technologies in oral drug delivery.Advanced drug delivery reviews · 2020
    Review
  13. Article
  14. Reversible inhibition of efflux transporters by hydrogel microdevices.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kimberly R KamUC Berkeley & UCSF Graduate Program in Bioengineering, 1700 4th Street, Building QB3 Room 204, UCSF Mission Bay Campus, San Francisco, California 94158, USA.
Laura A Walsh
Suzanne M Bock
Michael Koval
Kathleen E Fischer
Russell F Ross
Tejal A Desai

Funding

UCSF/UCB Joint Graduate Group in BIoengineeringT32GM008155 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DESAI, TEJAL A. · 1985 to 2020
$12.2M
Engineering Particle Nanostructure for Enhanced BioadhesionR21EB011664 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DESAI, TEJAL A. · 2010 to 2011
$403k
NIBIB NIH HHS R21 EB011664NIGMS NIH HHS T32 GM008155
6 · The paper itself

Abstract

Herein, we demonstrate that nanotopographical cues can be utilized to enable biologics >66 kDa to be transported across epithelial monolayers. When placed in contact with epithelial monolayers, nanostructured thin films loosen the epithelial barrier and allow for significantly increased transport of FITC-albumin, FITC-IgG, and a model therapeutic, etanercept. Our work highlights the potential to use drug delivery systems which incorporate nanotopography to increase the transport of biologics across epithelial tissue.

Indexed as

NanostructuresAlbuminsBiological ProductsEpitheliumImmunoglobulin GPermeabilityAlbuminsBiological ProductsImmunoglobulin G

Identifiers

PMID23186530
PMCPMC4418930

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.